Jin Medical International Ltd. (NASDAQ: ZJYL) Stock Competitors & Peer Comparison
See ZJYL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZJYL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZJYL | $2.06 | -9.65% | 16M | 12.75 | $0.16 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
ZJYL vs BDX Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BDX's P/E ratio is 11.62. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDX's ROE of +0.05%. Regarding short-term risk, ZJYL is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
ZJYL vs BDXA Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BDXA's P/E ratio is 45.70. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, ZJYL is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
ZJYL vs MDLN Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, MDLN has a market cap of 32.8B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while MDLN trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas MDLN's P/E ratio is 45.06. In terms of profitability, ZJYL's ROE is +0.04%, compared to MDLN's ROE of +0.07%. Regarding short-term risk, ZJYL is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
ZJYL vs WST Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas WST's P/E ratio is 41.19. In terms of profitability, ZJYL's ROE is +0.04%, compared to WST's ROE of +0.19%. Regarding short-term risk, ZJYL is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
ZJYL vs HOLX Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas HOLX's P/E ratio is 31.54. In terms of profitability, ZJYL's ROE is +0.04%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ZJYL is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HOLX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
ZJYL vs COO Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, COO has a market cap of 13.7B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while COO trades at $70.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas COO's P/E ratio is 15.42. In terms of profitability, ZJYL's ROE is +0.04%, compared to COO's ROE of +0.03%. Regarding short-term risk, ZJYL is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check COO's competition here
Becton, Dickinson and Company (NYSE: BDXB)
ZJYL vs BDXB Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ZJYL's ROE is +0.04%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, ZJYL is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
ZJYL vs BAX Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BAX's P/E ratio is 10.77. In terms of profitability, ZJYL's ROE is +0.04%, compared to BAX's ROE of -0.16%. Regarding short-term risk, ZJYL is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
ZJYL vs ATR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ATR's P/E ratio is 23.13. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATR's ROE of +0.14%. Regarding short-term risk, ZJYL is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
ZJYL vs AVTR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas AVTR's P/E ratio is 13.46. In terms of profitability, ZJYL's ROE is +0.04%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, ZJYL is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
ZJYL vs RGEN Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas RGEN's P/E ratio is 73.31. In terms of profitability, ZJYL's ROE is +0.04%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, ZJYL is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
ZJYL vs TFX Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas TFX's P/E ratio is 12.32. In terms of profitability, ZJYL's ROE is +0.04%, compared to TFX's ROE of -0.28%. Regarding short-term risk, ZJYL is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
ZJYL vs BLCO Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BLCO's P/E ratio is 24.88. In terms of profitability, ZJYL's ROE is +0.04%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, ZJYL is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
ZJYL vs STVN Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas STVN's P/E ratio is 31.81. In terms of profitability, ZJYL's ROE is +0.04%, compared to STVN's ROE of +0.10%. Regarding short-term risk, ZJYL is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
ZJYL vs MMSI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas MMSI's P/E ratio is 19.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ZJYL is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
ZJYL vs ICUI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ICUI's P/E ratio is 19.66. In terms of profitability, ZJYL's ROE is +0.04%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, ZJYL is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
ZJYL vs HAE Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas HAE's P/E ratio is 15.86. In terms of profitability, ZJYL's ROE is +0.04%, compared to HAE's ROE of +0.11%. Regarding short-term risk, ZJYL is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
ZJYL vs XRAY Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas XRAY's P/E ratio is 9.04. In terms of profitability, ZJYL's ROE is +0.04%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, ZJYL is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
ZJYL vs LMAT Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas LMAT's P/E ratio is 37.05. In terms of profitability, ZJYL's ROE is +0.04%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, ZJYL is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
ZJYL vs PLSE Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas PLSE's P/E ratio is -27.48. In terms of profitability, ZJYL's ROE is +0.04%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, ZJYL is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
ZJYL vs ATRC Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, ZJYL is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
ZJYL vs BLFS Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas BLFS's P/E ratio is -141.85. In terms of profitability, ZJYL's ROE is +0.04%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, ZJYL is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
ZJYL vs AZTA Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas AZTA's P/E ratio is 60.82. In terms of profitability, ZJYL's ROE is +0.04%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, ZJYL is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
ZJYL vs KMTS Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas KMTS's P/E ratio is -8.92. In terms of profitability, ZJYL's ROE is +0.04%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, ZJYL is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
ZJYL vs STAA Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas STAA's P/E ratio is 41.02. In terms of profitability, ZJYL's ROE is +0.04%, compared to STAA's ROE of -0.06%. Regarding short-term risk, ZJYL is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
ZJYL vs QDEL Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas QDEL's P/E ratio is 11.98. In terms of profitability, ZJYL's ROE is +0.04%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, ZJYL is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
ZJYL vs ATRI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, ZJYL is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
ZJYL vs ANGO Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ANGO's P/E ratio is -34.85. In terms of profitability, ZJYL's ROE is +0.04%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, ZJYL is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
ZJYL vs NNNN Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas NNNN's P/E ratio is 145.38. In terms of profitability, ZJYL's ROE is +0.04%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, ZJYL is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
ZJYL vs OSUR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas OSUR's P/E ratio is -4.78. In terms of profitability, ZJYL's ROE is +0.04%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, ZJYL is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
ZJYL vs SMTI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas SMTI's P/E ratio is -426.00. In terms of profitability, ZJYL's ROE is +0.04%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, ZJYL is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
ZJYL vs UTMD Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas UTMD's P/E ratio is 19.86. In terms of profitability, ZJYL's ROE is +0.04%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, ZJYL is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
ZJYL vs INFU Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas INFU's P/E ratio is 23.97. In terms of profitability, ZJYL's ROE is +0.04%, compared to INFU's ROE of +0.14%. Regarding short-term risk, ZJYL is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
ZJYL vs KRMD Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas KRMD's P/E ratio is -95.75. In terms of profitability, ZJYL's ROE is +0.04%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, ZJYL is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
ZJYL vs PDEX Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas PDEX's P/E ratio is 19.34. In terms of profitability, ZJYL's ROE is +0.04%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, ZJYL is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
ZJYL vs MBOT Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas MBOT's P/E ratio is -6.58. In terms of profitability, ZJYL's ROE is +0.04%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, ZJYL is more volatile compared to MBOT. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
ZJYL vs AKYA Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas AKYA's P/E ratio is -1.34. In terms of profitability, ZJYL's ROE is +0.04%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, ZJYL is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
ZJYL vs STSS Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas STSS's P/E ratio is -0.02. In terms of profitability, ZJYL's ROE is +0.04%, compared to STSS's ROE of -1.66%. Regarding short-term risk, ZJYL is more volatile compared to STSS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
ZJYL vs DXR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas DXR's P/E ratio is 27.33. In terms of profitability, ZJYL's ROE is +0.04%, compared to DXR's ROE of +0.22%. Regarding short-term risk, ZJYL is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
ZJYL vs OMIC Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ZJYL's ROE is +0.04%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, ZJYL is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
ZJYL vs IGAP Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ZJYL's ROE is +0.04%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, ZJYL is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
ZJYL vs NEPH Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas NEPH's P/E ratio is 50.86. In terms of profitability, ZJYL's ROE is +0.04%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, ZJYL is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
ZJYL vs MLSS Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, MLSS has a market cap of 34.5M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while MLSS trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas MLSS's P/E ratio is -6.50. In terms of profitability, ZJYL's ROE is +0.04%, compared to MLSS's ROE of -1.66%. Regarding short-term risk, ZJYL is more volatile compared to MLSS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MLSS's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
ZJYL vs POCI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas POCI's P/E ratio is -6.07. In terms of profitability, ZJYL's ROE is +0.04%, compared to POCI's ROE of -0.37%. Regarding short-term risk, ZJYL is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
ZJYL vs SDC Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas SDC's P/E ratio is -0.03. In terms of profitability, ZJYL's ROE is +0.04%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ZJYL is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
ZJYL vs HBIO Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas HBIO's P/E ratio is -16.81. In terms of profitability, ZJYL's ROE is +0.04%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, ZJYL is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
ZJYL vs IVC Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas IVC's P/E ratio is -0.79. In terms of profitability, ZJYL's ROE is +0.04%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ZJYL is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
ZJYL vs RVP Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas RVP's P/E ratio is -2.06. In terms of profitability, ZJYL's ROE is +0.04%, compared to RVP's ROE of -0.08%. Regarding short-term risk, ZJYL is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RVP's competition here
Femasys Inc. (NASDAQ: FEMY)
ZJYL vs FEMY Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas FEMY's P/E ratio is -10.25. In terms of profitability, ZJYL's ROE is +0.04%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, ZJYL is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
ZJYL vs RGNT Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas RGNT's P/E ratio is -0.08. In terms of profitability, ZJYL's ROE is +0.04%, compared to RGNT's ROE of N/A. Regarding short-term risk, ZJYL is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
ZJYL vs NSTG Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ZJYL's ROE is +0.04%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ZJYL is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
ZJYL vs NXGL Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas NXGL's P/E ratio is -1.13. In terms of profitability, ZJYL's ROE is +0.04%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, ZJYL is more volatile compared to NXGL. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
ZJYL vs POAI Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas POAI's P/E ratio is -0.03. In terms of profitability, ZJYL's ROE is +0.04%, compared to POAI's ROE of -107.05%. Regarding short-term risk, ZJYL is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
ZJYL vs LUCY Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas LUCY's P/E ratio is -0.39. In terms of profitability, ZJYL's ROE is +0.04%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, ZJYL is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
ZJYL vs MHUA Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas MHUA's P/E ratio is 0.25. In terms of profitability, ZJYL's ROE is +0.04%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, ZJYL is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
ZJYL vs NXGLW Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, ZJYL's ROE is +0.04%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, ZJYL is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
ZJYL vs GMVD Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ZJYL is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
ZJYL vs GMVDW Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ZJYL's ROE is +0.04%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, ZJYL is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
ZJYL vs AVGR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ZJYL's ROE is +0.04%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, ZJYL is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
ZJYL vs LUCYW Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, ZJYL's ROE is +0.04%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, ZJYL is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
ZJYL vs GCTK Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas GCTK's P/E ratio is -0.01. In terms of profitability, ZJYL's ROE is +0.04%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, ZJYL is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for ZJYL.Check GCTK's competition here
Apria, Inc. (NASDAQ: APR)
ZJYL vs APR Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, APR has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas APR's P/E ratio is 22.59. In terms of profitability, ZJYL's ROE is +0.04%, compared to APR's ROE of +9.81%. Regarding short-term risk, ZJYL is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
ZJYL vs IIN Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, IIN has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas IIN's P/E ratio is 226.45. In terms of profitability, ZJYL's ROE is +0.04%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ZJYL is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
ZJYL vs ALOG Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ALOG's P/E ratio is 40.93. In terms of profitability, ZJYL's ROE is +0.04%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, ZJYL is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
ZJYL vs ATRS Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ZJYL's ROE is +0.04%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ZJYL is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
ZJYL vs IVTY Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas IVTY's P/E ratio is -3.80. In terms of profitability, ZJYL's ROE is +0.04%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, ZJYL is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
ZJYL vs HRC Comparison July 2026
Jin Medical International Ltd. (NASDAQ: ZJYL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZJYL stands at 16M. In comparison, HRC has a market cap of 0. Regarding current trading prices, ZJYL is priced at $2.06 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZJYL currently has a P/E ratio of 12.75, whereas HRC's P/E ratio is 41.92. In terms of profitability, ZJYL's ROE is +0.04%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ZJYL is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for ZJYL.Check HRC's competition here